Alpha Thalassemia in Southeast Asia

jon lawrence apilan
24 Jul 202419:46

Summary

TLDRThe script discusses alpha thalassemia, a genetic disorder prevalent in Asia and the Mediterranean, associated with malaria protection. It covers its clinical significance, prevalence, molecular defects, and management strategies including genetic counseling and prenatal diagnosis, emphasizing its impact in Southeast Asia.

Takeaways

  • 🌏 Alpha thalassemia is a common genetic disorder prevalent in Asia, the Middle East, and Mediterranean countries, with increasing clinical significance in North America, Australia, and Europe due to migrations.
  • 🌡 It is associated with areas where malaria is or was endemic, suggesting a possible protective role of carriers against malaria, although the exact reason remains unknown.
  • 📊 A recent study in Thailand aimed to estimate the burden of alpha thalassemia using a comprehensive prevalence database for Southeast Asia, highlighting the need for more information on the disease.
  • 🧬 Alpha thalassemia is caused by deletions or mutations in the alpha globin genes, leading to decreased or absent production of alpha globin chains and an excess of other chains, which are nonfunctional and cause hemolysis.
  • 🔬 The clinical severity of alpha thalassemia correlates with the degree of alpha globin chain deficiency, which is a consequence of molecular defects in the alpha globin gene.
  • 🏥 Diagnosis of alpha thalassemia can be confirmed through laboratory tests and molecular techniques, including CBC, RBC indices, and hemoglobin electrophoresis.
  • 🧬 Molecular analysis is crucial for specific diagnosis, identifying common mutations in the alpha globin gene, especially in Southeast Asia where certain nondeletional mutations can be more clinically significant.
  • 🩺 Management of alpha thalassemia varies; silent carriers and those with alpha thalassemia trait may not need treatment, while hemoglobin H disease can range from mild to severe and may require regular transfusions.
  • ⚠️ Hydrops fetalis, the most severe form of alpha thalassemia, is typically fatal, but prenatal diagnosis and interventions like intrauterine transfusions can improve outcomes.
  • 👨‍👩‍👧‍👦 Genetic counseling and prenatal diagnosis are essential to prevent the perpetuation of the disease and to prepare for the potential health burdens associated with severe forms of the disorder.
  • 🏛 Community education and involvement are vital for the prevention and management of the long-term complications of alpha thalassemia, emphasizing the importance of awareness and proper healthcare systems.

Q & A

  • What is alpha thalassemia?

    -Alpha thalassemia is a genetic blood disorder characterized by reduced or absent production of alpha globin chains, leading to an imbalance in hemoglobin synthesis and causing various clinical manifestations.

  • Why is alpha thalassemia more prevalent in certain regions like Asia and the Middle East?

    -Alpha thalassemia is more prevalent in regions such as Asia and the Middle East because these areas are in tropical and subtropical regions where malaria is or was endemic, and carriers of the alpha globin gene mutations are thought to offer some protection against malaria.

  • What are the clinical significances of alpha thalassemia in different countries?

    -While alpha thalassemia is highly prevalent in Asia, the Middle East, and Mediterranean countries, its clinical significance is also noted in North America, Australia, and Europe due to massive migrations from areas where the disorder is endemic.

  • What is the estimated percentage of the world population that carries at least one alpha thalassemia variant?

    -It is estimated that up to 5% of the world population carries at least one variant of alpha thalassemia, with some populations reporting gene frequencies close to 80%.

  • What are the severe forms of alpha thalassemia that are seen in Southeast Asia?

    -In Southeast Asia, more severe forms of alpha thalassemia are observed, which can include hemoglobin H disease and hydrops fetalis, the latter of which is often lethal or incompatible with life.

  • What is the significance of the alpha and beta globin genes in the context of alpha thalassemia?

    -The alpha and beta globin genes are crucial for hemoglobin production. In alpha thalassemia, there are deletions or mutations in the alpha globin genes, leading to decreased or absent production of alpha globin chains and an excess of other globin chains, causing various clinical issues.

  • How are the different forms of alpha thalassemia classified based on the number of functional alpha genes?

    -The forms of alpha thalassemia are classified based on the number of functional alpha genes: silent carrier status with three functional genes, alpha thalassemia 3 with two functional genes, hemoglobin H disease with one functional gene, and hemoglobin Barts hydrops fetalis with no functional genes.

  • What are the common mutations observed in alpha thalassemia in Southeast Asia?

    -Common mutations in alpha thalassemia in Southeast Asia include deletions affecting one or two alpha genes, such as the Southeast Asian deletion, and nondeletional mutations that can have a more significant clinical impact, especially those affecting the alpha 2 globin gene.

  • How is alpha thalassemia diagnosed without the benefit of newborn screening results?

    -Diagnosis of alpha thalassemia without newborn screening results relies on a combination of history and physical examination, evidence of anemia, and laboratory tests such as complete blood count (CBC), red blood cell indices, hemoglobin electrophoresis, and molecular techniques.

  • What are the management strategies for different forms of alpha thalassemia?

    -Management of alpha thalassemia varies based on the form: silent carriers and alpha thalassemia trait may not require treatment, while hemoglobin H disease may require intermittent or regular blood transfusions, and hydrops fetalis may necessitate intrauterine interventions or stem cell transplantation.

  • Why is genetic counseling important in the context of alpha thalassemia?

    -Genetic counseling is important to inform at-risk couples about the potential for having children with severe forms of alpha thalassemia, such as hydrops fetalis, and to discuss options for prevention and management of the disorder.

  • What is the role of community education in the prevention and management of alpha thalassemia?

    -Community education is essential to raise awareness about alpha thalassemia, its symptoms, and the importance of diagnosis and management. This helps to prevent the perpetuation of the disorder within communities and ensures individuals receive appropriate care.

Outlines

00:00

🌏 Global Prevalence and Clinical Significance of Alpha Thalassemia

This paragraph discusses the widespread occurrence of alpha thalassemia, particularly in Asia, the Middle East, and Mediterranean countries. It notes the condition's clinical significance in regions like North America, Australia, and Europe, drawing parallels with other genetic disorders such as sickle cell anemia and beta thalassemia. The speaker highlights the correlation between the prevalence of alpha thalassemia and areas where malaria is or was endemic, suggesting a possible protective role against malaria for carriers of the condition. The paragraph also emphasizes the need for increased awareness and research in Thailand and Southeast Asia due to the high prevalence and clinical impact of severe forms of alpha thalassemia in these regions.

05:02

🧬 Genetic Mutations and Clinical Manifestations of Alpha Thalassemia

The second paragraph delves into the genetic aspects of alpha thalassemia, explaining the different forms of the condition based on the number of functional alpha genes. It describes silent alpha thalassemia, alpha thalassemia 3, hemoglobin H disease, and hemoglobin Barts hydrops fetalis, detailing their clinical implications and the potential for severe anemia. The speaker also discusses the types of mutations, predominantly deletions, that can lead to alpha thalassemia, and the significance of nondeletional mutations, especially those affecting the alpha 2 globin gene, which can result in more severe clinical manifestations. The paragraph concludes with a focus on common mutations in Southeast Asia, including the nondeletion variant seen in hemoglobin constant spring, and its increasing prevalence due to migration.

10:02

🩺 Diagnosis and Management of Alpha Thalassemia

This paragraph outlines the diagnostic process for alpha thalassemia, emphasizing the importance of laboratory tests such as CBC and RBC indices to identify anemia and microcytosis. It also mentions the use of molecular techniques for a definitive diagnosis. The speaker discusses the management of different forms of alpha thalassemia, noting that silent carriers typically do not require treatment, while individuals with hemoglobin H disease may need regular transfusions and are at risk of iron overload. Hydrops fetalis, a severe form of the disease, is highlighted as incompatible with life, although intrauterine transfusions have been used in some cases to improve outcomes. The paragraph concludes with a call for better data collection and molecular diagnosis to aid in the management of alpha thalassemia.

15:04

👨‍👩‍👧‍👦 Genetic Counseling and Public Health Implications of Alpha Thalassemia

The final paragraph focuses on the importance of genetic counseling and prenatal diagnosis in preventing the transmission of severe forms of alpha thalassemia. It discusses the risk of having a child with hydrops fetalis and the potential for parents who are carriers to have children with varying degrees of the disease. The speaker emphasizes the role of community education and the need for physicians to be trained in the diagnosis and management of alpha thalassemia, as it can present similarly to other common anemias. The paragraph also touches on the long-term complications of anemia and iron overload, highlighting the need for multi-specialty care and public health strategies to address these issues effectively.

Mindmap

Keywords

💡Alpha Thalassemia

Alpha Thalassemia is a genetic blood disorder characterized by a reduced or absent production of alpha globin chains in hemoglobin. It is the main theme of the video, which discusses its prevalence, clinical significance, and impact on populations, particularly in Southeast Asia. The script mentions various forms of the disease, such as silent carrier status, Hemoglobin H disease, and Hydrops Fetalis, which are all related to the number of functional alpha genes.

💡Genetic Abnormalities

Genetic abnormalities refer to any alteration in the genome that leads to disease or health conditions. In the context of the video, alpha thalassemia is one such genetic abnormality that is highly prevalent in certain regions. The script outlines how this genetic condition affects the production of hemoglobin, impacting the health of carriers and individuals with the disease.

💡Hemoglobin

Hemoglobin is a protein in red blood cells that binds oxygen and transports it throughout the body. The video explains that in alpha thalassemia, there is a disruption in the production of hemoglobin due to a deficiency in alpha globin chains, which affects the oxygen-carrying capacity of red blood cells.

💡Endemic

Endemic refers to a disease or condition that is regularly found among particular people or in a certain area. The script mentions that alpha thalassemia is found in tropical and subtropical areas where malaria is or was endemic, suggesting a possible evolutionary advantage for carriers of the alpha thalassemia trait in such regions.

💡Mutation

A mutation is a change in the DNA sequence that can lead to variations in genes. The video discusses how alpha thalassemia is caused by mutations or deletions in the alpha globin genes, resulting in a spectrum of disorders with varying clinical severity.

💡Clinical Significance

Clinical significance refers to the relevance or importance of a disease or condition in a medical context. The script emphasizes that while alpha thalassemia is common in certain regions, its clinical significance varies, with some populations experiencing more severe forms of the disease.

💡Carrier

A carrier in genetics is an individual who has a gene for a particular disease but does not show symptoms. The video explains that many people are carriers of the alpha thalassemia variant without showing clinical symptoms, yet they can pass the gene to their offspring.

💡Molecular Techniques

Molecular techniques are methods used to analyze and manipulate biological molecules, such as DNA. The script mentions that molecular techniques are used for the diagnosis of alpha thalassemia, allowing for the identification of specific mutations and deletions in the alpha globin genes.

💡Hemoglobinopathies

Hemoglobinopathies are a group of genetic disorders that affect the structure or production of hemoglobin. The video places alpha thalassemia within the context of hemoglobinopathies, discussing its prevalence and impact alongside other conditions like sickle cell anemia.

💡Genetic Counseling

Genetic counseling is the process of providing individuals and families with information on the implications of genetic disorders. The script highlights the importance of genetic counseling for families at risk of having children with alpha thalassemia, to prevent severe outcomes like Hydrops Fetalis.

💡Community Education

Community education refers to efforts to inform and engage communities about health issues. The video underscores the importance of educating communities about alpha thalassemia to prevent the perpetuation of the disease and manage its long-term complications effectively.

Highlights

Alpha thalassemia is a common genetic disorder prevalent in Asia, the Middle East, and Mediterranean countries.

The disorder is also seen in North America, Australia, and Europe, though its clinical significance varies.

Alpha thalassemias are associated with regions where malaria is endemic, suggesting a protective role for carriers against malaria.

The exact reason for the protective effect against malaria in carriers is still unknown despite extensive research.

In Southeast Asia, alpha thalassemia manifests in severe forms and is a significant health burden.

Massive migrations have spread the problem of alpha thalassemia to countries like Europe and North America.

An estimated 5% of the world population carries at least one alpha thalassemia variant.

Southeast Asia reports more severe forms of alpha thalassemia due to higher gene frequencies.

A recent study in Thailand aimed to estimate the burden of alpha thalassemia using a comprehensive prevalence database.

The study revealed a spatial distribution of alpha thalassemia alleles in Southeast Asia.

Alpha thalassemia is caused by deletions or mutations of the alpha globin gene, leading to decreased or no production of alpha globin chains.

Nonfunctional hemoglobins like hemoglobin Barts and hemoglobin H are produced in excess, causing hemolysis.

Different forms of alpha thalassemia are determined by the number of functional alpha genes.

Clinical classification of alpha thalassemia depends on the loss of alpha globin genes and the type of mutation.

There are 128 known deletions for alpha thalassemia, with most being deletions and some more clinically significant due to their impact on alpha chain production.

Non-deletion mutations affecting the alpha 2 globin gene can lead to more severe manifestations of the disease.

Common mutations in Southeast Asia include the non-deletion variant seen in Chinese sister hemoglobin constant spring.

Diagnosis of alpha thalassemia can be missed without newborn screening and requires a combination of history, physical examination, and laboratory tests.

Molecular techniques are used for specific diagnosis of alpha thalassemia, identifying common mutations.

Management of alpha thalassemia includes proper workup for carriers, especially if anemia develops, and avoiding prophylactic iron.

Hemoglobin H disease can range from mild to severe and may require regular transfusions, leading to iron overload.

Hydrops fetalis, the most severe form of alpha thalassemia, is often fatal, but some cases have survived with intrauterine transfusions and are candidates for stem cell transplant.

Genetic counseling and prenatal diagnosis are crucial in preventing the disease and managing long-term complications.

Community education and physician training are essential for the prevention and management of alpha thalassemia.

The prognosis for alpha thalassemia varies, with good outcomes for asymptomatic carriers but variable outcomes for hemoglobin H disease due to potential iron accumulation.

Transcripts

play00:00

alpha phalasinia is one of the most common uh

play00:02

modelling genetic abnormalities

play00:05

uh it is highly prevalent in the Asia

play00:09

in the Middle East in the Mediterranean countries

play00:14

however

play00:15

seen in clinical significance in other countries

play00:17

like the North America

play00:19

Australia and Europe this is the outline of my top

play00:25

no just like any other uh

play00:27

globing gene disorders like your

play00:29

or sickle cell anemia and your beta fallassemia

play00:33

your alpha fallassemias

play00:35

are found in the tropical and subtropical areas

play00:38

where malaria was or is endemic

play00:42

and it is thought that carriers of this immoglobin

play00:44

authorities offer Protection against malaria

play00:48

and the reason behind this is still unknown

play00:50

despite extensive research

play00:53

now as I've said before it is common in Asia

play00:56

and specifically in Southeast Asia

play00:58

where it's clinical significant is uh

play01:02

uh seen in different forms of alpha celacemias

play01:06

with severe manifestations however

play01:09

because of massive migrations

play01:11

this become a problem in other parts of the country

play01:15

like Europe and North America

play01:18

as of now it is estimated

play01:19

that up to 5% of the world population cares

play01:22

at least one alpha philassemia variant

play01:25

with some populations reporting gene frequencies

play01:27

close to 80% but it is more clinically significant in

play01:32

Southeast Asia where you see

play01:34

the more severe forms of alpha philassemia

play01:38

now this is why in Thailand

play01:40

uh

play01:42

knowing uh there's uh

play01:44

grooving

play01:44

demand for more information regarding the prevalence

play01:48

and

play01:49

estimates of health burden for this disease

play01:53

several studies were done in

play01:54

this is one of the most recent published study

play01:58

and this was done in Thailand

play02:00

where it aim to estimate

play02:02

the burden of alpha fellasinia in Thailand

play02:04

using a comprehensive prevalence database

play02:07

for Southeast Asia now this is uh

play02:10

this map is a uh

play02:13

reflection of the spatial distribution

play02:15

of the prevalence in the sample sizes

play02:18

no of your alpha alacemia alleles in the range or no

play02:23

as as a result of this study

play02:25

and this comprised countries like a Moja

play02:28

allows in Vietnam and of course Thailand

play02:31

in the because of this

play02:32

the result of the study estimated around 3,000 95

play02:43

who borns

play03:00

and this paper also highlights the need

play03:09

2 alpha globingine in your chromosome 16

play03:13

and 1 beta globingine in your

play03:27

and the last senior refers to a spectrum of disorders

play03:31

characterized by reduced or absent

play03:35

production of one or more non alpha

play03:39

in alpha global chains and

play03:42

this results in the disruption of the delicate balance

play03:47

oh as I've said before

play03:49

alpha phalascemia is due to deletions

play03:51

or mutation of your alpha globingine

play03:55

and what happens is that there will be decreased

play03:58

or option production of your

play04:00

alpha

play04:01

globin chain and as a result

play04:04

there will be excess production of

play04:07

your gamoglobin chains in the Newborn

play04:10

in these forms your hemoglobin Barts

play04:12

and after the Newborn period will be excess uh

play04:16

meta globin chain production in this

play04:22

to your hemoglobin each

play04:24

now this uh uh hemoglobins are nonfunctional

play04:29

they cannot deliver oxygen effectively

play04:32

and they stick to RBC membranes causing hemolysis

play04:37

now

play04:43

slide is a glowing chain plaster now depending

play04:58

functional alpha genes you will have

play05:01

the different forms of your alpha thalassemia

play05:04

so and you have a silent alpha thalassemia

play05:08

when when there is three functional gene in

play05:11

if only two functional genes

play05:14

you will have your alpha salascemia 3

play05:16

which can be homozygous or heterozygous

play05:19

and if only one functional gene

play05:22

alpha gene

play05:25

then you will have your hemoglobin H disease

play05:28

and of course if no functional gene

play05:32

then this will give rise to your hemoglobin uh

play05:36

Barts hydropsythalese

play05:38

which is lethal or not compatible with life

play05:43

now this is

play05:44

the clinical classification of alpha thalassemia

play05:46

or the genotype phenotype correlation

play05:49

and this depends on the neck loss of alphaglobin gene

play05:54

which can be due to the number of alphaglobin

play05:56

gene affected

play05:58

which alpha globe in low side is affected

play06:01

whether it's a deletional

play06:02

or nondeletional form of mutation

play06:05

or if it's a non deletional then there's no mutation

play06:10

partially or fully anemia at all

play06:13

while with those with alacemia

play06:15

treat will have MALD anemia and microsatosis

play06:19

and examination of your peripheral smear

play06:21

while your hemoglobin H

play06:23

disease can vary from moderate to severe anemia

play06:27

having mild jaundice and moderate hepatosplanomegaly

play06:31

and of course

play06:32

your hydropspitalis is not compatible with life

play06:36

fetuses born will have severe anemia

play06:38

journalists and edemaciitis Mark hepatospline omegaly

play06:43

skeletal and cardiovascular malformations uh

play06:46

will be noted

play06:49

now

play06:49

these are the different types of mutations in alpha

play06:52

palasinia

play06:53

most of these mutations are uh are are deletions

play06:58

no in fact

play06:59

today there are already 128 known deletions

play07:03

uh for alpha phalasinia and uh molecular defects

play07:09

no and most of these are uh deletions

play07:12

it can have small deletions

play07:14

where in 1 alpha gene is just uh

play07:16

affected and uh several recombinations are produced

play07:21

and these are the common mutations and uh uh that are

play07:25

are observed not uh listed in this line

play07:29

there can be large deletions involving two alpha genes

play07:33

in the most common of this is your Southeast Asia

play07:36

deletions

play07:38

however it is the non deletions that are considered uh

play07:43

sometimes more clinically significant

play07:45

no uh in fact this deletions

play07:49

this non deletions

play07:51

give rise to more severe reduction of your alpha chain

play07:55

cymme disease and this phenomenon may be explained

play07:58

but by the fact

play07:59

majority of these mutations affect your hemoglobin

play08:03

E2 gene this alpha 2

play08:06

globin gene is considered the dominant adult

play08:09

moglobin gene which is expressed at two to three fold

play08:12

higher levels than your alpha 1 globin gene

play08:15

at most mrna and protein levels

play08:18

so that when it is affected

play08:20

the transcription of this

play08:21

effective alpha 2 globin gene

play08:23

also interferes with your alpha 1

play08:26

further reducing alpha globin chain production

play08:29

more Malica say if your alpha 1 is affected

play08:32

there is a compensation

play08:34

or compensatory reaction of your alpha 2 globin gene

play08:38

however when your alpha 2 globin gene is affected

play08:42

it creates a more severe uh

play08:45

reduction in your alpha globe in gene production

play08:49

hence in more clinically significant manifestation

play08:53

now these

play08:53

are the common mutations

play08:55

in alpha thalassema in Southeast Asia

play08:58

and uh one of the most common

play09:01

non deletion variants in Southeast Asia

play09:04

among Chinese sister hemoglobin constant spring

play09:07

uh this hemoglobin constant spring is uh seen in

play09:12

has a gene frequency of 8%

play09:16

and this results from a mutation

play09:18

a termination cordon of your alpha tube globin gene

play09:21

which leads to synthesis

play09:22

the synthesis of unstable and elongated alpha globin

play09:26

ah chin additionally

play09:28

they have more AH30 one amino acids more

play09:33

and this is the most prevalent nondeletional ah

play09:36

alpha thalassemia in in in the region

play09:40

specifically in China and Southeast Asia

play09:43

and it is gained increase incidents

play09:47

nor there's increasing incidents

play09:49

in other parts of the world

play09:50

as I've said before because of migration

play09:54

and it creates a more

play09:56

a moderately severe form of alpha fallassemia uh

play10:00

with a binding of your uh

play10:02

alpha constant spring

play10:03

globin chain on the inner membrane of your red blood

play10:06

cell containing your hemoglobin constant spring

play10:09

and this can cost are increasing molyses

play10:11

and unusual pathombiology of red blood cells

play10:15

among patients are having this mutation

play10:18

now it can be missed not in uh HPLC

play10:21

but can be detected uh

play10:23

more efficiently in your capillary electrophoresis

play10:27

now how do we diagnose alpha phylescemia

play10:29

without the benefit of the results of Newborn screening

play10:33

well uh history and physical examination uh

play10:37

evidence of anemia can lead us to diagnosis

play10:40

but we need laboratory exams to uh uh

play10:46

make the diagnosis of

play10:47

complete diagnosis of alpha thalassemia

play10:50

and with your CBC and rbc in

play10:52

this is uh uh

play10:54

you can see uh degree of high hypochromia

play10:58

microsatosis in anemia

play11:00

based on the results of your CBC and RBC in disease

play11:03

and you will see in this slide that

play11:05

the level of your hemoglobin correlates well

play11:08

with the

play11:10

number of your functional genes

play11:12

no as you can see in the first graph

play11:16

if you have a normal uh genotype

play11:20

no mutations then you have a normal individual

play11:24

without any evidence of hemolysis or anemia

play11:27

without abnormality in your uh

play11:31

uh level of your

play11:33

uh mean cell volume or your MCV or your mean cell uh

play11:38

monogloping concentrations manifested in your uh

play11:42

RBC indecessors no

play11:44

so but normal no

play11:45

no genetic

play11:47

no gene abnormalities nor volume levels but as

play11:50

as the number of functional genes decreases

play11:53

you will see that the values of your ammogular

play11:56

being your MCV m m m C H also decreases

play12:02

this can also be evident

play12:03

upon examination of your peripheral smear

play12:06

where you will see hypochromia

play12:08

microcytosis target cell formation

play12:11

uh you can see occasional sphere sites and upon uh

play12:14

staining of your smear with your brilliant crusty blue

play12:18

you will see inclusion bodies

play12:21

now uh your hemoglobin A2 levels

play12:24

no by using HPLC and capillary electroforesis can

play12:29

you can also see no further decrease

play12:31

no in your hemoglobin A2 level

play12:34

and this correlates well

play12:35

with the number of functional genes uh

play12:38

uh involved and uh

play12:41

this is an example of an adult uh

play12:43

hemoglobin electrophoresis

play12:45

your hblc and capillary electrophoresis demonstrating

play12:49

demonstrating the presence of your hemoglobin H

play12:53

now

play12:54

you can specifically diagnose alpha thalassemia using

play12:58

uh molecular techniques

play12:59

and these are the common uh uh diagnostic uh way

play13:06

uh in in molecular biomolecular analysis K

play13:13

now let's go to alpha thalassemia management

play13:18

hopefully in the near future

play13:19

we'll have a complete no data in our registry

play13:23

the types of alpha thalassemia we have

play13:26

as well as using this molecular

play13:30

way of diagnosing alpha thalassemia

play13:32

the common mutations that will lead or are are um

play13:37

observed in our country

play13:40

how do we manage palasemia for alpha salassemia

play13:43

treat no need for treatment because they are

play13:46

they have no anemia or they might have anemia

play13:49

which can be very mild

play13:51

and the carriers of this alpha salassemia treat however

play13:56

should be properly worked up

play13:58

no uh especially if they develop anemia

play14:02

because

play14:03

there may be coexisting nutritional deficiencies

play14:06

and once diagnosed to have uh

play14:08

nutritional deficiency anemias

play14:11

then they should be treated accordingly

play14:13

however prophylactic iron should not

play14:16

never be given to carriers

play14:17

no alpha alacemia

play14:19

especially those who are at risk of developing

play14:22

iron overload

play14:24

how about immoglobin H disease

play14:26

it can be a mild to severe disorder

play14:29

and it depends on the mutation

play14:31

which influences the clinical severity

play14:34

the delusional type has milder disease

play14:37

with intermittent transfusion

play14:38

however

play14:39

the non delusional type has moderately to severe

play14:43

anemia which been omegaly

play14:45

it might require regular transfusions early in infancy

play14:49

up to late adulthood and because of this uh

play14:52

regular transmission they can have iron overload

play14:56

now for Hydrox fatales uh

play14:58

this is not compatible with life

play15:01

but in in some uh institutions

play15:03

intrauterine transfusions

play15:05

following early detection

play15:06

have resulted in the birth of this nonhydropic uh

play15:10

infants and this infants uh survive

play15:13

will survive because of this intervention

play15:17

are good candidates for him

play15:18

at the poetic stem cell transplant transplantation

play15:22

now genetic counseling and untenatal diagnosis

play15:26

is available in most part of uh

play15:29

South East Asia and this is important to prevent uh

play15:33

perpetration of the disease as well as uh

play15:37

having a child with a hydroxphatales

play15:40

now for example

play15:41

if you have a father who has mild anemia is considered

play15:44

uh the portal acemia trait

play15:46

having uh two genes missing

play15:48

and a mother with no signs and symptoms of anemia

play15:52

but uh they uh become parents

play15:56

no or there is always a chance of having a child

play16:01

no of uh having a hemoglovine age disease

play16:05

uh for every birth or for every pregnancy

play16:09

a 25% chance of having a child with multiple H disease

play16:14

now there will be children without anemia

play16:19

no normal no genes missing

play16:21

there can be uh

play16:22

children with silent carrier or uh with alacemia three

play16:27

however if one of the carrier is a homozygal

play16:30

then the risk of having a hemoglobin

play16:33

age disease increases to 50%

play16:36

for every pregnancy and when both parents

play16:39

carry an alpha salascemia mutation

play16:42

then this type of mutation

play16:44

the risk of their offspring having hemoglobin Barts

play16:47

hydrospitalis is 25% so important italegrate

play16:52

if you know the type of alpha celestinia

play16:55

you have type of mutation

play16:58

so that parents can be advised

play17:02

regarding the pregnancy of the mother

play17:06

now it's also important that

play17:08

position in the community

play17:10

are involved in the management of Palestinians

play17:13

individuals of one

play17:14

with one of the various forms of polycemia trait

play17:17

may be entirely as symptomatic

play17:18

unaware of their diagnosis

play17:20

and procreate with other individuals with the same

play17:22

trait

play17:23

thereby perpetuating the disorder within the community

play17:26

so important in a uh physicians know this

play17:30

and that

play17:30

they are trained in the diagnosis and management of

play17:33

alpha phalasemia

play17:34

since it has similar presentation with other

play17:36

common diseases causing anemia

play17:38

like nutritional anemis and chronic blood loss

play17:41

so Nissan Phosayne anemis know uh

play17:44

everybody stated as iron deficiency

play17:47

where us in Pala we have telesemia

play17:50

and of course physicians should know

play17:53

how to address the long term complications of anemia

play17:56

in iron overload

play17:57

and this requires multi specialty care

play18:00

under well formulated guidance

play18:03

prognosis is good generally

play18:04

for those who are asymptomatic and with bad anemia

play18:07

but the outcome for hemoglobin H disease is variable

play18:11

especially the long term problem of iron accumulation

play18:15

which can be a more severe problem

play18:18

for nondeletional type of alpha cell acemia

play18:22

and of course in general not

play18:24

this may depend on the awareness

play18:26

and availability of healthcare systems

play18:29

equipped to address the law

play18:30

this long term complications of the disease as well

play18:33

it's public health uh implication

play18:35

in summary I have presented alpha thalassemia

play18:39

this presentation

play18:40

patho physology as well as diagnosis and management

play18:45

and this are this my take home message

play18:48

alfasal acemia

play18:49

so why you distributed all over the world

play18:52

it is a clinically significant health

play18:54

uh problem in Southeast Asia

play18:57

or severe variants of the disease exist

play18:59

and there are four major phenotypes

play19:01

the silent carrier dalpathel acemia

play19:03

3HBH disease and hydrosphetolysis Vitalis

play19:08

and the clinical severity correlates well

play19:11

with a degree of alpha globin chain deficiency

play19:14

which is a consequence of molecular

play19:16

defects in the alpha globin gene

play19:18

diagnosis is confirmed by both laboratory

play19:21

and molecular techniques and the genetic and antinatal

play19:25

uh genetic and antinatal counseling are important

play19:28

to avoid pregnancies with mogulbin parts

play19:31

with Ali syndrome which causes munatal death

play19:35

positions and decision

play19:37

and community education are essential

play19:39

in the prevention

play19:40

in management long term complications

play19:44

thank you very much

play00:00

Ang alpha phalasinia ay isa sa pinakakaraniwang uh

play00:02

Pagmomodelo ng mga genetic abnormalities

play00:05

uh ito ay lubos na laganap sa Asya

play00:09

sa Gitnang Silangan sa mga bansang Mediteraneo

play00:14

gayunpaman

play00:15

nakikita sa klinikal na kahalagahan sa ibang mga bansa

play00:17

tulad ng North America

play00:19

Australia at Europe ito ang balangkas ng aking tuktok

play00:25

hindi tulad ng iba uh

play00:27

globing gene disorder tulad ng sa iyo

play00:29

o sickle cell anemia at ang iyong beta fallassemia

play00:33

iyong alpha fallassemias

play00:35

ay matatagpuan sa mga tropikal at subtropikal na lugar

play00:38

kung saan ang malaria ay o endemic

play00:42

at ito ay naisip na carrier ng immoglobin na ito

play00:44

Nag-aalok ang mga awtoridad ng Proteksyon laban sa malaria

play00:48

at ang dahilan sa likod nito ay hindi pa rin alam

play00:50

sa kabila ng malawak na pananaliksik

play00:53

ngayon gaya ng sinabi ko noon ay karaniwan na sa Asya

play00:56

at partikular sa Timog Silangang Asya

play00:58

kung saan ito ay klinikal na makabuluhan ay uh

play01:02

uh nakikita sa iba 't ibang anyo ng alpha celacemias

play01:06

na may malubhang manifestations gayunpaman

play01:09

dahil sa napakalaking migrasyon

play01:11

nagiging problema ito sa ibang bahagi ng bansa

play01:15

tulad ng Europa at Hilagang Amerika

play01:18

sa ngayon ay tinatantya

play01:19

na hanggang 5% ng populasyon ng mundo ay nagmamalasakit

play01:22

kahit isang variant ng alpha philassemia

play01:25

na may ilang populasyon na nag-uulat ng mga frequency ng gene

play01:27

malapit sa 80% ngunit ito ay mas klinikal na makabuluhan sa

play01:32

Southeast Asia kung saan mo nakikita

play01:34

ang mas malubhang anyo ng alpha philassemia

play01:38

ngayon ito ang dahilan kung bakit sa Thailand

play01:40

eh

play01:42

knowing uh meron uh

play01:44

pag-ukit

play01:44

demand para sa karagdagang impormasyon tungkol sa pagkalat

play01:48

at

play01:49

Mga pagtatantya ng pasanin sa kalusugan para sa sakit na ito

play01:53

ilang pag-aaral ang ginawa sa

play01:54

ito ay isa sa pinakahuling nai-publish na pag-aaral

play01:58

at ito ay ginawa sa Thailand

play02:00

kung saan nilalayon nitong tantiyahin

play02:02

ang pasanin ng alpha fellasinia sa Thailand

play02:04

gamit ang isang komprehensibong database ng prevalence

play02:07

para sa Southeast Asia ngayon ito ay uh

play02:10

ang mapa na ito ay isang uh

play02:13

salamin ng spatial distribution

play02:15

ng pagkalat sa mga laki ng sample

play02:18

wala sa iyong alpha alacemia alleles sa hanay o hindi

play02:23

bilang resulta ng pag-aaral na ito

play02:25

at ito ay binubuo ng mga bansa tulad ng isang Moja

play02:28

pinapayagan sa Vietnam at siyempre Thailand

play02:31

sa dahil dito

play02:32

ang resulta ng pag-aaral ay tinatayang nasa 3,000 95

play02:43

sino ang ipinanganak

play03:00

at itinatampok din ng papel na ito ang pangangailangan

play03:09

2 alpha globingine sa iyong chromosome 16

play03:13

at 1 beta globingine sa iyong

play03:27

at ang huling senior ay tumutukoy sa isang spectrum ng mga karamdaman

play03:31

nailalarawan sa pamamagitan ng nabawasan o wala

play03:35

produksyon ng isa o higit pang hindi alpha

play03:39

sa alpha global chain at

play03:42

Nagreresulta ito sa pagkagambala ng maselang balanse

play03:47

oh gaya ng sinabi ko kanina

play03:49

Ang alpha phalascemia ay dahil sa mga pagtanggal

play03:51

o mutation ng iyong alpha globingine

play03:55

at ang mangyayari ay mababawasan

play03:58

o opsyon na produksyon ng iyong

play04:01

globin chain at bilang isang resulta

play04:04

magkakaroon ng labis na produksyon ng

play04:07

Your Gamoglobin chain sa Bagong panganak

play04:10

sa mga form na ito ang iyong hemoglobin Barts

play04:12

at pagkatapos ng Newborn period ay magiging labis uh

play04:16

meta globin chain production dito

play04:22

sa iyong hemoglobin bawat isa

play04:24

ngayon itong uh uh hemoglobins ay nonfunctional

play04:29

hindi sila makapaghatid ng oxygen nang epektibo

play04:32

at dumidikit sila sa mga lamad ng RBC na nagdudulot ng hemolysis

play04:37

ngayon

play04:43

Ang slide ay isang kumikinang na chain plaster ngayon depende

play04:58

functional alpha genes na magkakaroon ka

play05:01

ang iba 't ibang anyo ng iyong alpha thalassemia

play05:04

So at mayroon kang tahimik na alpha thalassemia

play05:08

kapag may tatlong functional gene sa

play05:11

kung dalawang functional genes lang

play05:14

magkakaroon ka ng iyong alpha salascemia 3

play05:16

na maaaring homozygous o heterozygous

play05:19

at kung isang functional gene lang

play05:22

gene ng alpha

play05:25

pagkatapos ay magkakaroon ka ng iyong hemoglobin H disease

play05:28

at siyempre kung walang functional gene

play05:32

tapos ito ang magbubunga ng hemoglobin mo uh

play05:36

Ang hydropsythalese ni Barts

play05:38

na nakamamatay o hindi tugma sa buhay

play05:43

ngayon ito ay

play05:44

ang klinikal na pag-uuri ng alpha thalassemia

play05:46

o ang genotype phenotype correlation

play05:49

at ito ay depende sa pagkawala ng leeg ng alphaglobin gene

play05:54

na maaaring dahil sa bilang ng alphaglobin

play05:56

apektado ang gene

play05:58

aling alpha globe sa mababang bahagi ang apektado

play06:01

kung ito ay isang pagtanggal

play06:02

o nondeletional na anyo ng mutation

play06:05

o kung ito ay isang hindi pagtanggal, walang mutation

play06:10

Bahagyang o ganap na anemia sa lahat

play06:13

habang kasama ang mga may alacemia

play06:15

Magkakaroon ng MALD anemia at microsatosis ang treat

play06:19

at pagsusuri ng iyong peripheral smear

play06:21

habang ang iyong hemoglobin H

play06:23

Ang sakit ay maaaring mag-iba mula sa katamtaman hanggang sa malubhang anemia

play06:27

pagkakaroon ng banayad na paninilaw ng balat at katamtamang pagplano ng hepatos

play06:31

at syempre

play06:32

ang iyong hydropspitalis ay hindi tugma sa buhay

play06:36

Ang mga fetus na ipinanganak ay magkakaroon ng matinding anemia

play06:38

mga mamamahayag at edemaciitis Mark hepatospline omegaly

play06:43

skeletal at cardiovascular malformations uh

play06:46

mapapansin

play06:49

ngayon

play06:49

ito ang iba 't ibang uri ng mutasyon sa alpha

play06:52

Palatin

play06:53

karamihan sa mga mutasyon na ito ay uh ay mga pagtanggal

play06:58

hindi talaga

play06:59

ngayon ay mayroon nang 128 na kilalang pagtanggal

play07:03

uh para sa alpha phalasinia at uh molecular defects

play07:09

hindi at karamihan sa mga ito ay uh mga pagtanggal

play07:12

maaari itong magkaroon ng maliliit na pagtanggal

play07:14

saan sa 1 alpha gene ay uh lang

play07:16

apektado at uh ilang recombinations ang ginawa

play07:21

at ito ang mga karaniwang mutasyon at uh uh iyon

play07:25

ay sinusunod hindi uh nakalista sa linyang ito

play07:29

maaaring magkaroon ng malalaking pagtanggal na kinasasangkutan ng dalawang alpha genes

play07:33

sa pinakakaraniwan dito ay ang iyong Southeast Asia

play07:36

Mga pagtanggal

play07:38

gayunpaman, ang mga hindi pagtanggal ang itinuturing na uh

play07:43

minsan mas klinikal na makabuluhan

play07:45

hindi uh sa katunayan ang mga pagtanggal na ito

play07:49

itong hindi pagtanggal

play07:51

magbunga ng mas matinding pagbabawas ng iyong alpha chain

play07:55

cymme disease at ang hindi pangkaraniwang bagay na ito ay maaaring ipaliwanag

play07:58

ngunit sa katotohanan

play07:59

Karamihan sa mga mutasyon na ito ay nakakaapekto sa iyong hemoglobin

play08:03

E2 gene itong alpha 2

play08:06

Ang globin gene ay itinuturing na nangingibabaw na nasa hustong gulang

play08:09

Moglobin gene na ipinahayag sa dalawa hanggang tatlong beses

play08:12

mas mataas na antas kaysa sa iyong alpha 1 globin gene

play08:15

At karamihan sa mga antas ng mrna at protina

play08:18

para kapag naapektuhan

play08:20

ang transkripsyon nito

play08:21

epektibong alpha 2 globin gene

play08:23

nakakasagabal din sa iyong alpha 1

play08:26

higit pang pagbabawas ng produksyon ng alpha globin chain

play08:29

More Malica say kung apektado ang alpha 1 mo

play08:32

may kabayaran

play08:34

o compensatory reaction ng iyong alpha 2 globin gene

play08:38

gayunpaman kapag ang iyong alpha 2 globin gene ay apektado

play08:42

Lumilikha ito ng mas malala uh

play08:45

pagbawas sa iyong alpha globe sa paggawa ng gene

play08:49

samakatuwid sa mas klinikal na makabuluhang pagpapakita

play08:53

ngayon ang mga ito

play08:53

ay ang mga karaniwang mutasyon

play08:55

sa alpha thalassema sa Timog Silangang Asya

play08:58

at uh isa sa pinakakaraniwan

play09:01

mga variant ng hindi pagtanggal sa Southeast Asia

play09:04

sa mga Chinese kapatid na babae hemoglobin pare-pareho spring

play09:07

uh itong hemoglobin constant spring ay makikita sa

play09:12

ay may dalas ng gene na 8%

play09:16

at ito ay nagreresulta mula sa isang mutation

play09:18

isang termination cordon ng iyong alpha tube globin gene

play09:21

na humahantong sa synthesis

play09:22

ang synthesis ng hindi matatag at pinahabang alpha globin

play09:26

ah baba din

play09:28

mas marami silang AH30 isang amino acids pa

play09:33

at ito ang pinakalaganap na nondeletional ah

play09:36

alpha thalassemia sa in sa rehiyon

play09:40

partikular sa Tsina at Timog Silangang Asya

play09:43

at ito ay nakakuha ng pagtaas ng mga insidente

play09:47

o dumarami ang mga insidente

play09:49

sa ibang bahagi ng mundo

play09:50

gaya ng sinabi ko noon dahil sa migration

play09:54

at lumilikha ito ng higit pa

play09:56

isang katamtamang malubhang anyo ng alpha fallassemia uh

play10:00

na may pagkakatali ng iyong uh

play10:02

alpha pare-pareho ang tagsibol

play10:03

globin chain sa panloob na lamad ng iyong pulang dugo

play10:06

cell na naglalaman ng iyong hemoglobin constant spring

play10:09

at ito ay maaaring gastos ay pagtaas ng molyses

play10:11

at hindi pangkaraniwang pathombiology ng mga pulang selula ng dugo

play10:15

sa mga pasyente ay nagkakaroon ng mutation na ito

play10:18

ngayon maaari itong makaligtaan hindi sa uh HPLC

play10:21

pero pwedeng ma-detect uh

play10:23

mas mahusay sa iyong capillary electrophoresis

play10:27

ngayon paano natin masuri ang alpha phylescemia

play10:29

nang walang pakinabang ng mga resulta ng Newborn screening

play10:33

Well uh kasaysayan at pisikal na pagsusuri uh

play10:37

Ang katibayan ng anemia ay maaaring humantong sa amin sa diagnosis

play10:40

pero kailangan namin ng laboratory exams para uh uh

play10:46

gawin ang diagnosis ng

play10:47

kumpletong diagnosis ng alpha thalassemia

play10:50

at kasama ang iyong CBC at rbc

play10:52

ito ay uh uh

play10:54

makikita mo ang uh degree ng mataas na hypochromia

play10:58

Microsatosis sa anemia

play11:00

batay sa mga resulta ng iyong CBC at RBC sa sakit

play11:03

at makikita mo sa slide na ito na

play11:05

ang antas ng iyong hemoglobin ay mahusay na nakakaugnay

play11:08

kasama ang

play11:10

bilang ng iyong mga functional na gene

play11:12

hindi tulad ng makikita mo sa unang graph

play11:16

kung mayroon kang isang normal na uh genotype

play11:20

walang mutations tapos may normal kang indibidwal

play11:24

nang walang anumang katibayan ng hemolysis o anemia

play11:27

walang abnormalidad sa uh mo

play11:31

uh level mo

play11:33

uh mean cell volume o ang MCV mo o ang mean cell mo uh

play11:38

Ang mga monogloping na konsentrasyon ay ipinakita sa iyong uh

play11:42

Mga index ng RBC no

play11:44

So pero normal no

play11:45

walang genetic

play11:47

walang mga abnormalidad sa gene o mga antas ng volume ngunit bilang

play11:50

habang bumababa ang bilang ng mga functional genes

play11:53

makikita mo na ang mga halaga ng iyong ammogular

play11:56

Ang pagiging MCV mo m m C H ay nababawasan din

play12:02

ito ay maaari ding maging maliwanag

play12:03

sa pagsusuri ng iyong peripheral smear

play12:06

kung saan makikita mo ang hypochromia

play12:08

Microcytosis target na pagbuo ng cell

play12:11

uh makikita mo ang paminsan-minsang mga sphere site at sa uh

play12:14

paglamlam ng iyong pahid ng iyong makinang na magaspang na asul

play12:18

makikita mo ang inclusion bodies

play12:21

ngayon uh ang iyong mga antas ng hemoglobin A2

play12:24

hindi sa pamamagitan ng paggamit ng HPLC at capillary electroforesis maaari

play12:29

wala ka ring makikitang pagbaba

play12:31

wala sa iyong hemoglobin A2 level

play12:34

at ito ay may kaugnayan nang maayos

play12:35

sa dami ng functional genes uh

play12:38

uh kasali at uh

play12:41

ito ay isang halimbawa ng isang matanda uh

play12:43

electrophoresis ng hemoglobin

play12:45

iyong hblc at capillary electrophoresis na nagpapakita

play12:49

Pagpapakita ng presensya ng iyong hemoglobin H

play12:53

ngayon

play12:54

maaari mong partikular na masuri ang alpha thalassemia gamit

play12:58

uh mga pamamaraan ng molekular

play12:59

at ito ang karaniwang uh uh diagnostic uh na paraan

play13:06

uh sa molecular biomolecular analysis K

play13:13

ngayon pumunta tayo sa alpha thalassemia management

play13:18

sana sa malapit na hinaharap

play13:19

magkakaroon kami ng kumpletong walang data sa aming registry

play13:23

ang mga uri ng alpha thalassemia na mayroon tayo

play13:26

pati na rin ang paggamit ng molekular na ito

play13:30

paraan ng pag-diagnose ng alpha thalassemia

play13:32

ang mga karaniwang mutasyon na hahantong o ay um

play13:37

naobserbahan sa ating bansa

play13:40

Paano natin pinamamahalaan ang palasemia para sa alpha salassemia

play13:43

hindi na kailangan ng paggamot dahil sila ay

play13:46

wala silang anemia o baka may anemia sila

play13:49

na maaaring maging napaka banayad

play13:51

at ang mga carrier ng alpha salassemia na ito ay gumagamot gayunpaman

play13:56

dapat maayos na magtrabaho

play13:58

No uh lalo na kung nagkakaroon sila ng anemia

play14:02

kasi

play14:03

Maaaring may magkakasamang kakulangan sa nutrisyon

play14:06

at minsang na-diagnose na may uh

play14:08

Mga anemia sa kakulangan sa nutrisyon

play14:11

pagkatapos ay dapat silang tratuhin nang naaayon

play14:13

gayunpaman ang prophylactic iron ay hindi dapat

play14:16

hindi kailanman ibibigay sa mga carrier

play14:17

walang alpha alacemia

play14:19

lalo na ang mga nasa panganib na umunlad

play14:22

sobrang karga ng bakal

play14:24

paano ang sakit na immoglobin H

play14:26

maaari itong maging banayad hanggang malubhang karamdaman

play14:29

at depende ito sa mutation

play14:31

nakakaimpluwensya sa klinikal na kalubhaan

play14:34

ang uri ng delusional ay may mas banayad na sakit

play14:37

na may pasulput-sulpot na pagsasalin ng dugo

play14:38

gayunpaman

play14:39

ang hindi delusional na uri ay may katamtaman hanggang malubha

play14:43

Anemia na naging omegaly

play14:45

Maaaring mangailangan ito ng mga regular na pagsasalin sa maagang pagkabata

play14:49

hanggang late adulthood at dahil dito uh

play14:52

Regular transmission maaari silang magkaroon ng iron overload

play14:56

ngayon para sa Hydrox fatales uh

play14:58

hindi ito tugma sa buhay

play15:01

ngunit sa ilang uh institusyon

play15:03

Mga pagsasalin ng intrauterine

play15:05

kasunod ng maagang pagtuklas

play15:06

Nagresulta sa pagsilang nitong nonhydropic uh

play15:10

mga sanggol at ang mga sanggol na ito uh ay nabubuhay

play15:13

mabubuhay dahil sa interbensyong ito

play15:17

ay mabubuting kandidato para sa kanya

play15:18

At ang patula stem cell transplant transplantation

play15:22

ngayon ay genetic counseling at untenatal diagnosis

play15:26

ay magagamit sa karamihan ng bahagi ng uh

play15:29

Timog Silangang Asya at ito ay mahalaga upang maiwasan uh

play15:33

Perpetration ng sakit pati na rin uh

play15:37

pagkakaroon ng anak na may hydroxphatales

play15:40

ngayon halimbawa

play15:41

kung mayroon kang isang ama na may banayad na anemia ay isinasaalang-alang

play15:44

uh ang katangian ng portal acemia

play15:46

pagkakaroon ng uh dalawang gene na nawawala

play15:48

at isang ina na walang palatandaan at sintomas ng anemia

play15:52

pero uh naging magulang na sila

play15:56

wala o laging may pagkakataon na magkaroon ng anak

play16:01

No of uh pagkakaroon ng hemoglovine age disease

play16:05

uh para sa bawat kapanganakan o para sa bawat pagbubuntis

play16:09

isang 25% na posibilidad na magkaroon ng anak na may multiple H disease

play16:14

ngayon ay magkakaroon ng mga batang walang anemia

play16:19

No normal walang genes na nawawala

play16:21

pwede naman eh

play16:22

mga batang may silent carrier o uh na may alacemia tatlo

play16:27

gayunpaman kung ang isa sa carrier ay isang homozygal

play16:30

pagkatapos ay ang panganib ng pagkakaroon ng hemoglobin

play16:33

Ang sakit sa edad ay tumataas sa 50%

play16:36

para sa bawat pagbubuntis at kapag ang parehong mga magulang

play16:39

magdala ng alpha salascemia mutation

play16:42

pagkatapos ang ganitong uri ng mutation

play16:44

ang panganib ng kanilang mga supling na magkaroon ng hemoglobin Barts

play16:47

Hydrospitalis ay 25% kaya mahalagang italegrate

play16:52

kung alam mo ang uri ng alpha celestinia

play16:55

mayroon kang uri ng mutation

play16:58

para mapayuhan ang mga magulang

play17:02

tungkol sa pagbubuntis ng ina

play17:06

ngayon mahalaga din yan

play17:08

posisyon sa komunidad

play17:10

ay kasangkot sa pamamahala ng mga Palestinian

play17:13

mga indibidwal ng isa

play17:14

na may isa sa iba 't ibang anyo ng katangian ng polycemia

play17:17

Maaaring ganap na kasing sintomas

play17:18

hindi alam ang kanilang diagnosis

play17:20

at magkaanak sa ibang mga indibidwal na may pareho

play17:22

katangian

play17:23

sa gayon ay nagpapatuloy ang kaguluhan sa loob ng komunidad

play17:26

Napakahalaga sa isang uh na alam ito ng mga manggagamot

play17:30

at iyon

play17:30

sila ay sinanay sa pagsusuri at pamamahala ng

play17:34

dahil ito ay may katulad na pagtatanghal sa iba

play17:36

Mga karaniwang sakit na nagdudulot ng anemia

play17:38

tulad ng nutritional anemis at talamak na pagkawala ng dugo

play17:41

So alam ng Nissan Phosayne anemis uh

play17:44

sinabi ng lahat bilang kakulangan sa bakal

play17:47

Where us in Pala meron tayong telesemia

play17:50

at siyempre dapat malaman ng mga manggagamot

play17:53

kung paano tugunan ang mga pangmatagalang komplikasyon ng anemia

play17:56

sa sobrang karga ng bakal

play17:57

at nangangailangan ito ng multi specialty na pangangalaga

play18:00

Under well formulated guidance

play18:03

Ang pagbabala ay mabuti sa pangkalahatan

play18:04

Para sa mga asymptomatic at may masamang anemia

play18:07

ngunit ang kinalabasan para sa hemoglobin H disease ay variable

play18:11

lalo na ang pangmatagalang problema ng akumulasyon ng bakal

play18:15

na maaaring maging isang mas matinding problema

play18:18

para sa nondeletional na uri ng alpha cell acemia

play18:22

at siyempre sa pangkalahatan ay hindi

play18:24

ito ay maaaring depende sa kamalayan

play18:26

at pagkakaroon ng mga sistema ng pangangalagang pangkalusugan

play18:29

nilagyan upang tugunan ang batas

play18:30

ito pangmatagalang komplikasyon ng sakit pati na rin

play18:33

ito ay pampublikong kalusugan uh implikasyon

play18:35

sa buod ay ipinakita ko ang alpha thalassemia

play18:39

ang pagtatanghal na ito

play18:40

Patolohiya ng patho pati na rin ang diagnosis at pamamahala

play18:45

at ito ang aking mensahe sa pag-uwi

play18:48

alphasal acemia

play18:49

kaya bakit mo ipinamahagi sa buong mundo

play18:52

ito ay isang klinikal na makabuluhang kalusugan

play18:54

uh problema sa Southeast Asia

play18:57

o umiiral ang mga malubhang variant ng sakit

play18:59

at mayroong apat na pangunahing phenotypes

play19:01

ang tahimik na carrier dalpathel acemia

play19:03

3HBH sakit at hydrosphetolysis Vitalis

play19:08

at ang klinikal na kalubhaan ay mahusay na nauugnay

play19:11

na may antas ng kakulangan sa alpha globin chain

play19:14

na bunga ng molekular

play19:16

mga depekto sa alpha globin gene

play19:18

Ang diagnosis ay kinumpirma ng parehong laboratoryo

play19:21

at mga molecular technique at ang genetic at antinatal

play19:25

uh mahalaga ang genetic at antinatal counseling

play19:28

upang maiwasan ang pagbubuntis na may mga bahagi ng mogulbin

play19:31

With Ali syndrome na nagiging sanhi ng unang kamatayan

play19:35

mga posisyon at desisyon

play19:37

at ang edukasyon sa komunidad ay mahalaga

play19:39

sa pag-iwas

play19:40

sa pamamahala ng pangmatagalang komplikasyon

play19:44

maraming salamat

Rate This

5.0 / 5 (0 votes)

相关标签
Alpha ThalassemiaGenetic DisordersSoutheast AsiaHealth BurdenMolecular DefectsClinical SignificanceHemoglobinopathiesGenetic CounselingPrenatal DiagnosisPublic Health
您是否需要英文摘要?